Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations

Journal article in the International Journal of Tuberculosis and Lung Disease

From:
Department for International Development
Published
1 January 2015
Document Type:
Journal Article
Theme:
Health
Authors:
Rodrigues, C., Shetty, A., Ajbani, K., Catanzaro, A., Georghiou, S.B., Kambli, P., Khillari, A., Nikam, C., Rodwell, T.C., Udwadia, Z.

Abstract

The purpose of the study was to correlate gyrA mutations found in Mycobacterium tuberculosis isolates using the GenoType® MTBDRsl assay with minimum inhibitory concentrations of the fluoroquinolone levofloxacin

Citation

Kambli, P.; Ajbani, K.; Nikam, C.; Khillari, A.; Shetty, A.; Udwadia, Z.; Georghiou, S.B.; Rodwell, T.C.; Catanzaro, A.; Rodrigues, C. Determination of MICs of levofloxacin for IMycobacterium tuberculosisI with IgyrIA mutations. International Journal of Tuberculosis and Lung Disease (2015) 19 (10) 1227-1229. [DOI: 10.5588/ijtld.14.0277]

Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations

Published 1 January 2015
Contents